Skip to content
  • Bio-made medicine

    Bio-made medicine

  • Green building materials

    Green building materials

  • Clean water

    Clean water

  • Safe food

    Safe food

  • Healthy personal care

    Healthy personal care

  • High performance bioplastics

    High performance bioplastics

The chemistry of everyday life, now made with enzymes.

The first carbon negative molecule factory that can scale to meet the world’s needs.

  • Massively scales

    Using proprietary engineered enzymes, Solugen scales synthetic biology quickly and efficiently. Fermentation and costly immobilization are not required.

  • Safe and natural

    We use safe feedstocks such as sugars, air, and carbon dioxide.

  • Zero emissions

    No air emissions, no wastewater emissions.

  • Scales faster

    Solugen goes from 0.0004L well plates to its 40,000L enzymatic reactor in months, not decades.

  • Cost efficient

    Feedstock yield losses are the most expensive part of a traditional thermochemical or fermentation manufacturing process. The Bioforge platform enables 1 ton of feedstock to produce 1 ton of product.


3D rendering of the Bioforge

We combine the best elements of fermentation with the best elements of petrochemical processing to create the world’s first carbon negative molecular manufacturing platform: the Bioforge™.

At 10,000 ton per year capacity, the Bioforge is the first manufacturing plant permitted in Houston without wastewater discharge or air emissions. It is powered by renewable wind energy.

The Bioforge achieves highly profitable and carbon negative molecular manufacturing by simultaneously satisfying four parameters: biobased feedstocks, high selectivity, high yields, and high throughput. This enables the Bioforge to convert inexpensive feedstock directly into valuable product molecules while avoiding the formation of waste products.

Our Story

A long-standing poker game with a group of University of Texas Southwestern medical students in Dallas brought Gaurab Chakrabarti and Sean Hunt together.

Gaurab, getting his MD/PhD, was researching a drug candidate for pancreatic cancer. Hunt was a grad student at MIT studying chemical engineering. They began discussing how to use enzymes in an industrial, chemical process, and now they have 500,000 sq ft of manufacturing space across two facilities. They are looking forward to taking on the chemicals industry at scale, one molecule at a time.